Editor’s Pick: Precision Medicine in Neurology: Advancing Care for Female Patients

Growing evidence suggests that biological sex influences disease risk, clinical presentation, treatment response, and prognosis across neurological conditions. Despite this increasing awareness of important sex differences, neurological research and clinical care remain insufficiently tailored to females. In this review, the authors highlight the importance of integrating sex-specific considerations into precision medicine for neurological disorders. Focusing on five high-prevalence and high-burden neurological conditions (epilepsy, migraine, stroke, multiple sclerosis, and neurodegenerative diseases), this review identifies critical knowledge gaps and actionable opportunities for advancing care for females. Such gaps and opportunities include: 1) improved pregnancy and lactation data in epilepsy; 2) hormonal influences across the menstrual cycle, pregnancy, and menopause in migraine; 3) sex-based disparities in symptom recognition, treatment access, and rehabilitation for stroke patients; 4) the influence of sex hormones on disease onset, progression, and prognosis in multiple sclerosis; and 5) sex differences in pathophysiology and clinical trajectories in neurodegenerative diseases. This review proposes a roadmap for integrating sex-based considerations into three key domains: clinical care, research, and neurology training. Prioritising and advancing these initiatives is essential for improving neurological care and represents a critical step towards equitable precision medicine.

Authors

Institutions

Publication Details

Journal
EMJ Neurology
Published
2025-08-05
DOI
https://doi.org/10.33590/emjneurol/hrfb2147
Primary Topic
Pharmacological Effects and Toxicity Studies
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Editor’s Pick: Precision Medicine in Neurology: Advancing Care for Female Patients

Maria Teresa Ferretti, Mar Tintoré, Gennarina Arabia, Mafalda Soares et al.
EMJ Neurology
Pharmacological Effects and Toxicity Studies
article

Editor’s Pick: Precision Medicine in Neurology: Advancing Care for Female Patients

Maria Teresa Ferretti, Mar Tintoré, Gennarina Arabia, Mafalda Soares, Michele Romoli, Addie Peretz, Elena Moro, Katarina Rukavina, Esther Bui, Vanessa Freire de Carvalho, Marianne deVisser
article en

Abstract

Growing evidence suggests that biological sex influences disease risk, clinical presentation, treatment response, and prognosis across neurological conditions. Despite this increasing awareness of important sex differences, neurological research and clinical care remain insufficiently tailored to females. In this review, the authors highlight the importance of integrating sex-specific considerations into precision medicine for neurological disorders. Focusing on five high-prevalence and high-burden neurological conditions (epilepsy, migraine, stroke, multiple sclerosis, and neurodegenerative diseases), this review identifies critical knowledge gaps and actionable opportunities for advancing care for females. Such gaps and opportunities include: 1) improved pregnancy and lactation data in epilepsy; 2) hormonal influences across the menstrual cycle, pregnancy, and menopause in migraine; 3) sex-based disparities in symptom recognition, treatment access, and rehabilitation for stroke patients; 4) the influence of sex hormones on disease onset, progression, and prognosis in multiple sclerosis; and 5) sex differences in pathophysiology and clinical trajectories in neurodegenerative diseases. This review proposes a roadmap for integrating sex-based considerations into three key domains: clinical care, research, and neurology training. Prioritising and advancing these initiatives is essential for improving neurological care and represents a critical step towards equitable precision medicine.

EMJ Neurology
Universitat Autònoma de Barcelona (ES), University Health Network (CA), University of Lisbon (PT), Inserm (FR), University of Toronto (CA), Centre Hospitalier Universitaire de Grenoble (FR), Karolinska Institutet (SE), Magna Graecia University (IT), Hospital de São José (PT), Amsterdam Neuroscience (NL), Centre for Movement Disorders (CA), Ospedale “M. Bufalini” di Cesena (IT), Istituto delle Scienze Neurologiche di Bologna (IT), Vall d'Hebron Hospital Universitari (ES), Neurologisches Fachkrankenhaus für Bewegungsstörungen/Parkinson (DE), Hospital de Santa Maria (PT), Grenoble Institute of Neurosciences (FR), Ontario Brain Institute (CA), Université Grenoble Alpes (FR), Stanford University (US)
Bayer, Biogen, Teva Pharmaceutical Industries, LivaNova, Horizon Therapeutics, Eisai
Good health and well-being
Openalex Percentile: Top 72%
Pharmacological Effects and Toxicity Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.